Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-19-0375
Abstract: Purpose: Cellular immunotherapies are currently being explored to eliminate highly invasive and chemoradioresistant glioblastoma (GBM) cells involved in rapid relapse. We recently showed that concomitant stereotactic injections of nonalloreactive allogeneic Vγ9Vδ2 T lymphocytes eradicate zoledronate-primed…
read more here.
Keywords:
gbm cells;
glioblastoma;
reactivity;
nkg2d controls ... See more keywords